Di Francesco A, Di Germanio C, Bernier M, De Cabo R. A time to fast. Science. 2018 Nov 16;362(6416):770–5. DOI: 10.1126/science.aau2095
Originalquelle öffnen ↗Quellenverzeichnis
In diesem digitalen Quellenverzeichnis finden Sie die 668 Literaturangaben zum Buch „90 plus und fit wie ein Turnschuh“.
Die Sammlung umfasst wissenschaftliche Originalarbeiten, Übersichtsarbeiten, Leitlinien sowie weiterführende Fachliteratur. Soweit vorhanden, sind die Veröffentlichungen über ihre DOI oder die jeweilige Internetadresse direkt erreichbar.
Über die Suchfunktion können Sie gezielt nach Quellen-Nummern, Autoren oder Veröffentlichungstiteln suchen.
668 Quellen gefunden · Anzeige 601–620
Sarkar TJ, Quarta M, Mukherjee S, Colville A, Paine P, Doan L, et al. Transient non-integrative expression of nuclear reprogramming factors promotes multifaceted amelioration of aging in human cells. Nat Commun. 2020 Mar 24;11(1):1545. DOI: 10.1038/s41467-020-15174-3
Originalquelle öffnen ↗Takahashi K, Yamanaka S. Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors. Cell. 2006 Aug;126(4):663–76. DOI: 10.1016/j.cell.2006.07.024
Originalquelle öffnen ↗Omole AE, Fakoya AOJ. Ten years of progress and promise of induced pluripotent stem cells: historical origins, characteristics, mechanisms, limitations, and potential applications. PeerJ. 2018 May 11;6:e4370. DOI: 10.7717/peerj.4370
Originalquelle öffnen ↗FDA go-ahead to test cellular rejuvenation therapy in humans. Nat Biotechnol. 2026 Feb;44(2):164–164. DOI: 10.1038/s41587-026-03037-z
Originalquelle öffnen ↗Kulkarni AS, Aleksic S, Berger DM, Sierra F, Kuchel GA, Barzilai N. Geroscience‐guided repurposing of FDA‐approved drugs to target aging: A proposed process and prioritization. Aging Cell. 2022 Apr;21(4):e13596. DOI: 10.1111/acel.13596
Originalquelle öffnen ↗Hickson LJ, Langhi Prata LGP, Bobart SA, Evans TK, Giorgadze N, Hashmi SK, et al. Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease. EBioMedicine. 2019 Sep;47:446–56. DOI: 10.1016/j.ebiom.2019.08.069
Originalquelle öffnen ↗Khan M. Funding Life-Extension Research. Cold Spring Harb Perspect Med. 2023 Dec;13(12):a041208. DOI: 10.1101/cshperspect.a041208
Originalquelle öffnen ↗Moel M, Harinath G, Lee V, Nyquist A, Morgan SL, Isman A, et al. Influence of rapamycin on safety and healthspan metrics after one year: PEARL trial results. Aging. 2025 Apr 4. DOI: 10.18632/aging.206235
Originalquelle öffnen ↗Feng Y, Barthez M, Wang Y, Chen Y, Qiu H, Wang CL, et al. Late-life semaglutide treatment slows ageing and extends lifespan in female mice. Nature. 2026 Sep 10;657(8131):469–76. DOI: 10.1038/s41586-026-10940-7
Originalquelle öffnen ↗Corley MJ, Dwaraka VB, Pang AP, Labbato D, Smith R, Ross Eckard A, et al. Semaglutide slows epigenetic aging in a randomized trial of HIV-associated lipohypertrophy. Nat Commun. 2026 May 19;17(1):6606. DOI: 10.1038/s41467-026-72861-3
Originalquelle öffnen ↗Katsuumi G, Minamino T. Dissecting out the unexpected effects of SGLT2 inhibitors on human aging. The Journal of Clinical Endocrinology & Metabolism. 2026 Jul 15;111(8):2154–65. DOI: 10.1210/clinem/dgag207
Originalquelle öffnen ↗Miller RA, Harrison DE, Allison DB, Bogue M, Debarba L, Diaz V, et al. Canagliflozin extends life span in genetically heterogeneous male but not female mice. JCI Insight. 2020 Nov 5;5(21):e140019. DOI: 10.1172/jci.insight.140019
Originalquelle öffnen ↗Nie J, Semwal MK, Acosta FM, et al. SAT671 SGLT2 Inhibition Decreases Adipose Tissue And Global Inflammaging Profile Of Older Obese Adults With Pre-Diabetes. Kongressabstract. Journal of the Endocrine Society. 2023;7(Supplement_1):bvad114.119. DOI: 10.1210/jendso/bvad114.119
Originalquelle öffnen ↗Harrison DE, Strong R, Alavez S, Astle CM, DiGiovanni J, Fernandez E, et al. Acarbose improves health and lifespan in aging HET3 mice. Aging Cell. 2019 Apr;18(2):e12898. DOI: 10.1111/acel.12898
Originalquelle öffnen ↗Gallagher C, Emmanuel OO. NAD+ supplementation for anti-aging and wellness: A PRISMA-guided systematic review of preclinical and clinical evidence. Ageing Research Reviews. 2026 Apr;116:103057. DOI: 10.1016/j.arr.2026.103057
Originalquelle öffnen ↗Conboy IM, Conboy MJ, Wagers AJ, Girma ER, Weissman IL, Rando TA. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature. 2005 Feb;433(7027):760–4. DOI: 10.1038/nature03260
Originalquelle öffnen ↗Sinha M, Jang YC, Oh J, Khong D, Wu EY, Manohar R, et al. Restoring Systemic GDF11 Levels Reverses Age-Related Dysfunction in Mouse Skeletal Muscle. Science. 2014 May 9;344(6184):649–52. DOI: 10.1126/science.1251152
Originalquelle öffnen ↗Egerman MA, Cadena SM, Gilbert JA, Meyer A, Nelson HN, Swalley SE, et al. GDF11 Increases with Age and Inhibits Skeletal Muscle Regeneration. Cell Metabolism. 2015 Jul;22(1):164–74. DOI: 10.1016/j.cmet.2015.05.010
Originalquelle öffnen ↗Gaudilliere B, Xue L, Tsai AS, Gao X, McAllister TN, Tingle M, et al. Infusion of young donor plasma components in older patients modifies the immune and inflammatory response to surgical tissue injury: a randomized clinical trial. J Transl Med. 2025 Feb 14;23(1):183. DOI: 10.1186/s12967-025-06215-w
Originalquelle öffnen ↗